dihydroergotamine has been researched along with sumatriptan in 102 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.98) | 18.7374 |
1990's | 58 (56.86) | 18.2507 |
2000's | 27 (26.47) | 29.6817 |
2010's | 16 (15.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamblin, MW; Metcalf, MA | 1 |
Adham, N; Bard, JA; Branchek, TA; Vaysse, P; Weinshank, RL; Zgombick, J | 1 |
Arrang, JM; Diaz, J; Leurs, R; Ruat, M; Schwartz, JC; Tardivel-Lacombe, J; Traiffort, E | 1 |
Izzarelli, DG; Lewis-Higgins, L; Palmer, D; Parker, EM; Shapiro, RA | 1 |
Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R | 1 |
Boess, FG; Monsma, FJ; Sleight, AJ | 1 |
Audia, JE; Krushinski, JH; Lucaites, VL; Nelson, DL; Schaus, JM; Wainscott, DB; Zgombick, JM | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Diener, HC; Grotemeyer, KH; Pfaffenrath, V; Soyka, D | 1 |
Liaño, H | 1 |
Buzzi, MG; Dimitriadou, V; Moskowitz, MA; Theoharides, TC | 1 |
Boccalini, P; Moskowitz, MA; Nozaki, K | 1 |
den Boer, MO; Saxena, PR; Somers, JA | 1 |
Ollat, H | 1 |
Buzzi, MG; Moskowitz, MA | 2 |
Deliganis, AV; Peroutka, SJ | 1 |
Goadsby, PJ; Jauslin, P; Lance, JW | 1 |
Buzzi, MG; Carter, WB; Heath, H; Moskowitz, MA; Shimizu, T | 1 |
den Boer, MO; Heiligers, JP; Saxena, PR | 1 |
McCarthy, BG; Peroutka, SJ | 1 |
Titus, F | 3 |
Alberca, R; Arenas, C; Casado, JL; Moreno, A; Serrano, V | 1 |
Ferrari, MD; Haan, J | 1 |
Wilkinson, M | 1 |
Lipton, RB; Silberstein, SD | 1 |
Kumar, KL | 1 |
Bax, WA | 1 |
Landy, S; Lobo, BL | 1 |
d'Allens, H; Henry, P | 1 |
Solomon, GD | 1 |
Bax, WA; Ferrari, MD; Haan, J; Meijler, WJ; Timmerman, H; van Coevorden, RS | 1 |
Edvinsson, L; Goadsby, PJ | 1 |
Peroutka, SJ | 1 |
Raskin, NH | 1 |
Van Mil, JW | 1 |
Du, XY; Saxena, PR; Schoemaker, RG; Van Gelderen, EM | 1 |
Castanon, N; Chauveau, J; Chaveau, J; Hen, R; Macor, JE; Moskowitz, MA; Scearce, K; Waeber, C; Yu, XJ | 1 |
Mathew, NT; Ravishankar, K; Sanin, LC | 1 |
Le Force, B; Margul, B; Ricalde, O; Saper, J; Winner, P | 1 |
Ashford, E; Bertin, L; Bès, A; Pilgrim, AJ; Touchon, J | 1 |
Lucker, C; Mathew, NT; Tietjen, GE | 1 |
Lambert, G; Michalicek, J | 1 |
Catarci, T; Cerbo, R | 1 |
Mathew, NT | 1 |
Audinot-Bouchez, V; Chaput, C; Conte, C; Lavielle, G; Lochon, S; Millan, MJ; Newman-Tancredi, A; Verrièle, L | 1 |
Kaplan, B; Swain, RA | 1 |
Björkman, S; Edvinsson, L; Nilsson, F; Nilsson, T; Nordström, CH | 1 |
Steurer, J | 1 |
Bonnafous, R; John, GW; Valentin, JP | 1 |
Finkel, AG; Howard, JF; Mann, JD | 1 |
Becker, WJ; Riess, CM; Robertson, M | 1 |
Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Van Gompel, P; Vanhoenacker, P; Wouters, R | 1 |
Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR | 1 |
John, GW; Le Grand, B; Vié, B | 1 |
Kozma, CM; Lawrence, BJ; Payne, K | 1 |
Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM | 1 |
Logemann, CD; Rankin, LM | 1 |
Lutz, G; Pradalier, A; Vincent, D | 1 |
Ashford, E; Boureau, F; Esperanca, P; Kappos, L; Schoenen, J | 1 |
Tfelt-Hansen, P | 2 |
Krumholz, W; Menges, T; Ogal, H; Szalay, G | 1 |
Hargreaves, RJ; Williamson, DJ | 1 |
Steiner, TJ; Tfelt-Hansen, P | 1 |
Akhtar, ND; Murray, MA; Rothner, AD | 1 |
Rothner, AD | 1 |
Yamane, K | 1 |
Ferrari, MD | 1 |
Autret, A; Mondon, K | 1 |
Diamond, S; Wenzel, R | 1 |
Csiba, L; Ficzere, A | 1 |
Aubel, B; Bourgoin, S; Hamon, M; Kayser, V | 1 |
Vaitkus, A; Vilionskis, A | 1 |
Bigal, ME; Tepper, SJ | 1 |
Markley, HG | 1 |
Andrews, PL; Cheng, FH; Moreaux, B; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Wan, C | 1 |
Auvin, S; Cuvellier, JC; Joriot, S; Vallée, L | 1 |
Kabbouche, MA; Linder, SL | 1 |
Berger, MY; Bruijn, JK; Damen, L; Koes, BW; Passchier, J; Verhagen, AP | 1 |
Gano, D; Gerretsen, P; Silver, S | 1 |
Nahas, SJ; Silberstein, SD | 1 |
Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP | 1 |
Silberstein, SD | 1 |
Detwiler, TJ; Kane, SA; Lynch, JJ; Regan, CP | 1 |
Rothrock, JF | 1 |
Derry, CJ; Derry, S; Moore, RA | 1 |
Peatfield, R | 1 |
Dahlöf, C; Maassen Van Den Brink, A | 1 |
Goadsby, PJ; Mathias, CJ; Viana, M | 1 |
Argüelles, CF; Godínez-Chaparro, B; Granados-Soto, V; López-Santillán, FJ; Villalón, CM | 1 |
Lanteri-Minet, M | 1 |
Chan, KY; Danser, AJ; de Vries, R; Dirven, CM; Kori, SH; Labruijere, S; MaassenVanDenBrink, A; van den Bogaerdt, AJ | 1 |
Ward, TN | 1 |
Charles, A; Goadsby, PJ; Hansen, JM | 1 |
34 review(s) available for dihydroergotamine and sumatriptan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Current treatment of migraine].
Topics: Adult; Child; Dihydroergotamine; Ergotamine; Female; Humans; Indoles; Male; Methysergide; Metoclopramide; Middle Aged; Migraine Disorders; Sulfonamides; Sumatriptan; Time Factors; Vasoconstrictor Agents | 1992 |
[Serotonin agonists and antagonists in migraine].
Topics: Benzoxepins; Contraindications; Cyproheptadine; Dihydroergotamine; Ergotamine; Histamine H1 Antagonists; Humans; Indoles; Methysergide; Migraine Disorders; Phenothiazines; Pizotyline; Receptors, Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1992 |
The trigemino-vascular system and migraine.
Topics: Blood Proteins; Calcitonin Gene-Related Peptide; Cerebrovascular Disorders; Cranial Nerve Diseases; Dihydroergotamine; Dura Mater; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Substance P; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents | 1992 |
[Treatment of the acute migraine attack].
Topics: Acute Disease; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1995 |
[Status migrainosus].
Topics: Brain; Dihydroergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1995 |
Acute treatment of migraine attacks.
Topics: Adolescent; Adult; Analgesics; Child; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Pregnancy; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1995 |
Migraine treatment: the British perspective.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Sumatriptan; United Kingdom | 1994 |
Overview of diagnosis and treatment of migraine.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Antagonists; Sumatriptan | 1994 |
Recent advances in the acute management of migraine and cluster headaches.
Topics: Analgesics; Butorphanol; Capsaicin; Cluster Headache; Dihydroergotamine; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Sumatriptan; Tolmetin | 1994 |
Therapeutic advances in migraine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Female; Humans; Indoles; Male; Migraine Disorders; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid | 1993 |
5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine.
Topics: Adenylyl Cyclases; Dihydroergotamine; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan | 1993 |
Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Phenothiazines; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid | 1993 |
[Symptomatic treatment of cluster headache].
Topics: Alkaloids; Analgesics; Capsaicin; Cluster Headache; Cocaine; Dihydroergotamine; Ergotamine; Humans; Lidocaine; Methoxyflurane; Narcotics; Oxygen; Sumatriptan; Vasoconstrictor Agents | 1995 |
Serotonin 1D (5-HT1D) agonists and other agents in acute migraine.
Topics: Acute Disease; Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Drug Interactions; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents | 1997 |
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Chronic Disease; Cluster Headache; Dihydroergotamine; Female; GABA Agents; Headache; Humans; Male; Migraine Disorders; Nortriptyline; Physical Exertion; Psychomotor Performance; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sports; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil | 1997 |
Newer intranasal migraine medications.
Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2000 |
Neurogenic inflammation in the context of migraine.
Topics: Animals; Blood Proteins; Bosentan; Calcitonin Gene-Related Peptide; Capillary Permeability; Dihydroergotamine; Dura Mater; Humans; Migraine Disorders; Narcotics; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT1F; Receptors, Neurokinin-1; Receptors, Serotonin; Serotonin Receptor Agonists; Skull; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents; Vasodilation | 2001 |
Complicated migraine and migraine variants.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Diagnosis, Differential; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Sumatriptan | 2001 |
[Migraine: selection of therapeutic agents to be applied during its attack].
Topics: Analgesics; Antiemetics; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Sumatriptan | 2001 |
Practical approaches to migraine management.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Psychotropic Drugs; Secondary Prevention; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 2002 |
[Treatment of migraine in patients with hypertension and ischemic heart disease].
Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2002 |
Ergotamine, dihydroergotamine: current uses and problems.
Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan | 2001 |
[The problems of migraine headache treatment].
Topics: Aged; Analgesics; Analgesics, Non-Narcotic; Aspirin; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Stress, Psychological; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents | 2002 |
Ergotamine and dihydroergotamine: a review.
Topics: Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome | 2003 |
Topical agents in the treatment of cluster headache.
Topics: Administration, Intranasal; Administration, Topical; Capsaicin; Cluster Headache; Cocaine; Dihydroergotamine; Humans; Lidocaine; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 2003 |
[Pharmacologic treatment of acute migraine attack in children].
Topics: Acetaminophen; Acute Disease; Administration, Intranasal; Administration, Oral; Adolescent; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psychology; Child; Dihydroergotamine; Humans; Ibuprofen; Injections, Intravenous; Life Style; Migraine Disorders; Relaxation Therapy; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 2005 |
Acute treatment of pediatric headache in the emergency department and inpatient settings.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Child; Dihydroergotamine; Drug Therapy, Combination; Emergency Service, Hospital; Headache; Hospitalization; Humans; Metoclopramide; Serotonin Receptor Agonists; Sumatriptan | 2005 |
Symptomatic treatment of migraine in children: a systematic review of medication trials.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Child; Child, Preschool; Controlled Clinical Trials as Topic; Dihydroergotamine; Female; Humans; Ibuprofen; Ketorolac; Male; Migraine Disorders; Prochlorperazine; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan | 2005 |
Acute treatment of paediatric migraine: a meta-analysis of efficacy.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Dihydroergotamine; Drug Evaluation; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Placebos; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2008 |
Meeting acute migraine treatment needs through novel treatment formulations.
Topics: Analgesics, Non-Narcotic; Diclofenac; Dihydroergotamine; Drug Administration Routes; Drug Delivery Systems; Drug Prescriptions; Humans; Migraine Disorders; Sumatriptan | 2010 |
Sumatriptan (intranasal route of administration) for acute migraine attacks in adults.
Topics: Acute Disease; Administration, Intranasal; Adult; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Pain Management; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2012 |
Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
Topics: Animals; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Sumatriptan; Treatment Outcome | 2012 |
What's new in the migraine attack treatment.
Topics: Analgesics; Calcitonin Gene-Related Peptide Receptor Antagonists; Dihydroergotamine; Humans; Migraine Disorders; Pain Management; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Transcranial Magnetic Stimulation | 2013 |
6 trial(s) available for dihydroergotamine and sumatriptan
Article | Year |
---|---|
Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Dihydroergotamine; Double-Blind Method; Drug Interactions; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Sumatriptan | 1993 |
A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan | 1996 |
A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
Topics: Administration, Intranasal; Adult; Dihydroergotamine; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Sumatriptan | 1996 |
Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Dihydroergotamine; Humans; Middle Aged; Migraine Disorders; Retrospective Studies; Sumatriptan; Vasoconstrictor Agents | 1996 |
A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine.
Topics: Adult; Aged; Belgium; Cross-Over Studies; Dihydroergotamine; Double-Blind Method; Female; France; Humans; Male; Middle Aged; Migraine Disorders; Portugal; Sumatriptan; Switzerland; Vasoconstrictor Agents | 2000 |
Reduced efficacy of sumatriptan in migraine with aura vs without aura.
Topics: Adult; Databases, Factual; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Migraine with Aura; Migraine without Aura; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents | 2015 |
62 other study(ies) available for dihydroergotamine and sumatriptan
Article | Year |
---|---|
Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
Topics: Amino Acid Sequence; Base Sequence; Cloning, Molecular; Cyclic AMP; GTP-Binding Proteins; Humans; Molecular Sequence Data; Pertussis Toxin; Receptors, Serotonin; Virulence Factors, Bordetella | 1991 |
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
Topics: Adenylyl Cyclases; Base Sequence; Cloning, Molecular; DNA Primers; Humans; Molecular Sequence Data; Receptors, Serotonin; Sequence Alignment; Sequence Homology, Amino Acid; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction | 1993 |
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Brain; CHO Cells; Cricetinae; Cyclic AMP; DNA; Genomic Library; Kinetics; Lysergic Acid Diethylamide; Mianserin; Molecular Sequence Data; Multigene Family; Oligodeoxyribonucleotides; Organ Specificity; Rats; Receptors, Serotonin; Restriction Mapping; Serotonin; Serotonin Receptor Agonists; Transfection | 1993 |
Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Binding, Competitive; Chlorocebus aethiops; Cloning, Molecular; COS Cells; DNA Primers; Ergolines; Glutamic Acid; Humans; Isoleucine; Kinetics; Ligands; Lysine; Models, Structural; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Protein Structure, Secondary; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Serine; Serotonin; Transfection | 1996 |
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents | 1996 |
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
Topics: Adenylyl Cyclases; Amino Acid Substitution; Binding Sites; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Ligands; Lysergic Acid Diethylamide; Mutagenesis, Site-Directed; Mutation; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1998 |
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.
Topics: Animals; Benzamides; Brain; Cells, Cultured; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Ligands; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Serotonin Receptor Agonists; Transfection; Tritium | 2005 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
[Treatment of cluster headache. Recommendations of the German Migraine and Headache Society].
Topics: Cluster Headache; Combined Modality Therapy; Dihydroergotamine; Ergotamine; Humans; Indoles; Lidocaine; Oxygen Inhalation Therapy; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1992 |
5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation.
Topics: Animals; Axons; Dihydroergotamine; Dura Mater; Electric Stimulation; Endothelium, Vascular; Indoles; Male; Mast Cells; Muscle, Smooth, Vascular; Platelet Activation; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vascular Headaches; Venules | 1992 |
CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.
Topics: Animals; Animals, Newborn; Capsaicin; Carrageenan; Dihydroergotamine; Formaldehyde; Gene Expression Regulation, Neoplastic; Guinea Pigs; Immunohistochemistry; In Vitro Techniques; Indoles; Meninges; Nasal Mucosa; Proto-Oncogene Proteins c-fos; Pyridines; Pyrroles; Rats; Sulfonamides; Sumatriptan | 1992 |
Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.
Topics: Animals; Arteriovenous Anastomosis; Dihydroergotamine; Dura Mater; Ergotamine; Hemodynamics; Indoles; Microspheres; Migraine Disorders; Regional Blood Flow; Sulfonamides; Sumatriptan; Swine; Vasoconstrictor Agents | 1992 |
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Cattle; Caudate Nucleus; Dihydroergotamine; Ergotamine; Indoles; Kinetics; Methysergide; Migraine Disorders; Radioligand Assay; Receptors, Serotonin; Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Verapamil | 1991 |
Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
Topics: Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Capillary Permeability; Cerebrovascular Circulation; Cranial Sinuses; Dihydroergotamine; Electric Stimulation; Indoles; Male; Mast Cells; Migraine Disorders; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vasoconstrictor Agents | 1991 |
The hospital management of severe migrainous headache.
Topics: Adolescent; Adult; Aged; Child; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Indoles; Lidocaine; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Sulfonamides; Sumatriptan | 1991 |
Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion.
Topics: Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Cranial Sinuses; Dihydroergotamine; Dura Mater; Electric Stimulation; Indoles; Male; Rats; Rats, Inbred Strains; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vasoconstrictor Agents | 1991 |
Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.
Topics: Animals; Arteriovenous Anastomosis; Brain Chemistry; Carotid Arteries; Coronary Circulation; Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; Hemodynamics; Indoles; Methiothepin; Muscle, Smooth, Vascular; Oxygen Consumption; Receptors, Serotonin; Sulfonamides; Sumatriptan; Swine; Vasoconstrictor Agents | 1991 |
Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175).
Topics: Animals; Cattle; Dihydroergotamine; In Vitro Techniques; Indoles; Radioligand Assay; Rats; Receptors, Neurotransmitter; Receptors, Serotonin; Sulfonamides; Sumatriptan; Swine | 1989 |
Drugs for migraine.
Topics: Adrenergic beta-Antagonists; Analgesics; Dihydroergotamine; Humans; Migraine Disorders; Sumatriptan | 1995 |
[Multiple value of sumatriptan above that of ergot alkaloids still not proven].
Topics: Coronary Vessels; Dihydroergotamine; Ergotamine; Humans; Sumatriptan | 1994 |
Recommendations for the emergency treatment of migraine headache.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Dexamethasone; Dihydroergotamine; Emergency Medical Services; Humans; Ketorolac; Migraine Disorders; Sumatriptan; Tolmetin | 1994 |
[Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Topics: Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1993 |
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
Topics: Adolescent; Adult; Animals; Blood Vessels; Cats; Cerebrovascular Circulation; Dihydroergotamine; Female; Humans; Indoles; Laser-Doppler Flowmetry; Male; Middle Aged; Migraine Disorders; Neuropeptides; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vasoconstrictor Agents | 1993 |
[Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Topics: Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Therapeutic Equivalency; Vasoconstrictor Agents | 1993 |
Carotid blood flow distribution, haemodynamics and inotropic responses following calcitonin gene-related peptide in the pig.
Topics: Animals; Arteriovenous Anastomosis; Calcitonin Gene-Related Peptide; Carotid Artery, Common; Dihydroergotamine; Heart Atria; Heart Ventricles; Hemodynamics; Humans; In Vitro Techniques; Microspheres; Myocardial Contraction; Sumatriptan; Swine; Vasoconstrictor Agents | 1995 |
5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
Topics: Animals; Capillary Permeability; Dihydroergotamine; Dipeptides; Mice; Mice, Knockout; Pyridines; Pyrroles; Pyrrolidines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion | 1996 |
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studies; Furosemide; Headache; Humans; Intracranial Pressure; Male; Middle Aged; Migraine Disorders; Obesity; Papilledema; Pseudotumor Cerebri; Sumatriptan | 1996 |
Serotonin syndrome complicating migraine pharmacotherapy.
Topics: Adult; Autonomic Nervous System Diseases; Dihydroergotamine; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Injections, Intravenous; Injections, Subcutaneous; Lithium; Mental Disorders; Migraine Disorders; Movement Disorders; Serotonin Receptor Agonists; Sumatriptan; Syndrome | 1996 |
Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation.
Topics: Animals; Blood Pressure; Carotid Arteries; Cats; Dihydroergotamine; Dose-Response Relationship, Drug; Heart Rate; Injections, Intravenous; Meningeal Arteries; Migraine Disorders; Regional Blood Flow; Sumatriptan; Trigeminal Ganglion; Vascular Resistance; Vasoconstrictor Agents | 1996 |
Subcutaneous dihydroergotamine vs subcutaneous sumatriptan.
Topics: Dihydroergotamine; Humans; Injections, Subcutaneous; Migraine Disorders; Sumatriptan | 1996 |
[The treatment of migraine].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Nicardipine; Nimodipine; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1997 |
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Cell Membrane; Cricetinae; Dihydroergotamine; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Lisuride; Methysergide; Migraine Disorders; Piperazines; Piperidines; Pizotyline; Propranolol; Propylamines; Protein Binding; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 1997 |
Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins.
Topics: Cerebral Arteries; Cerebral Veins; Dihydroergotamine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Intracranial Pressure; Serotonin Receptor Agonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents | 1997 |
[Critical evaluation of "guidelines"].
Topics: Adult; Dihydroergotamine; Female; Humans; Migraine Disorders; Practice Guidelines as Topic; Quality Assurance, Health Care; Sumatriptan; Switzerland | 1998 |
Contractile responses evoked by dihydroergotamine, naratriptan and sumatriptan in the canine isolated coronary artery.
Topics: Animals; Coronary Vessels; Dihydroergotamine; Dogs; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Piperidines; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 1998 |
Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications.
Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Myasthenia Gravis; Recurrence; Serotonin Receptor Agonists; Sumatriptan | 1998 |
Episodic cluster headache in a community: clinical features and treatment.
Topics: Adaptation, Psychological; Adult; Aged; Analgesics; Cluster Headache; Dihydroergotamine; Emergency Service, Hospital; Female; Hospitals; Humans; Male; Middle Aged; Oxygen; Physicians; Quality of Life; Sleep; Sumatriptan; Surveys and Questionnaires; Tooth Extraction; Vasoconstrictor Agents | 1998 |
Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Topics: Adenylyl Cyclases; Animals; Benzopyrans; Cell Line; Cell Membrane; Cloning, Molecular; Dihydroergotamine; Humans; Ligands; Mice; Propylamines; Pyrimidines; Rats; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Vasoconstrictor Agents | 1998 |
Coronary side-effect potential of current and prospective antimigraine drugs.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 1998 |
Effects of sumatriptan on coronary flow and left ventricular function in the isolated perfused guinea pig heart.
Topics: Animals; Coronary Circulation; Diastole; Dihydroergotamine; Endothelium, Vascular; Guinea Pigs; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Oxadiazoles; Oxazoles; Oxazolidinones; Perfusion; Piperazines; Rabbits; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Ventricular Function, Left | 1998 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 1999 |
Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan.
Topics: Amnesia, Transient Global; Brain Infarction; Dihydroergotamine; Female; Humans; Injections, Subcutaneous; Middle Aged; Migraine Disorders; Sumatriptan; Vasoconstrictor Agents | 2000 |
Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies.
Topics: Dihydroergotamine; Humans; Migraine Disorders; Nebulizers and Vaporizers; Sumatriptan; Vasoconstrictor Agents | 2000 |
[Effect of migraine medications on monocyte chemotaxis] .
Topics: Adult; Analgesics; Aspirin; Chemotaxis, Leukocyte; Dihydroergotamine; Humans; Immune Tolerance; Male; Metoclopramide; Metoprolol; Migraine Disorders; Propranolol; Sumatriptan | 2000 |
Sumatriptin vs dihydroergotamine: patient preference.
Topics: Administration, Inhalation; Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan | 2001 |
Status migrainosus in children and adolescents.
Topics: Adolescent; Child; Diagnosis, Differential; Dihydroergotamine; Drug Therapy, Combination; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Meperidine; Methylprednisolone; Migraine Disorders; Prednisolone; Sumatriptan | 2001 |
Sumatriptan by injection.
Topics: Clinical Trials as Topic; Dihydroergotamine; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Migraine Disorders; Sumatriptan; Treatment Outcome | 2001 |
[Migraine and facial pain].
Topics: Adult; Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Child; Diagnosis, Differential; Dihydroergotamine; Facial Pain; Female; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Oxygen Inhalation Therapy; Psychotherapy; Serotonin Antagonists; Sumatriptan; Time Factors; Trigeminal Neuralgia; Vasoconstrictor Agents | 2001 |
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Topics: Animals; Dihydroergotamine; Disease Models, Animal; Male; Migraine Disorders; Oxazolidinones; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Nerve Diseases; Tryptamines | 2002 |
Headaches that could spell trouble.
Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders; Sumatriptan | 2004 |
Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Butanols; Capsaicin; Cyclooxygenase Inhibitors; Dihydroergotamine; Diphenhydramine; Diterpenes; Domperidone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Indomethacin; Malates; Methysergide; Metoclopramide; Migraine Disorders; Ondansetron; Piperidines; Ruthenium Red; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists; Shrews; Sumatriptan; Time Factors; Tropanes; Vomiting | 2005 |
Triptans: actions and reactions.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Herpes Simplex; Herpesvirus 2, Human; Humans; Migraine Disorders; Neuralgia, Postherpetic; Pyrrolidines; Serotonin Receptor Agonists; Skin; Sumatriptan; Tryptamines | 2008 |
Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines | 2010 |
Effect of calcitonin gene-related peptide receptor antagonism on the systemic blood pressure responses to mechanistically diverse vasomodulators in conscious rats.
Topics: Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Carotid Arteries; Dihydroergotamine; Dose-Response Relationship, Drug; Hemodynamics; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents | 2010 |
Commentary.
Topics: Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 2011 |
Headache currents commentary.
Topics: Analgesics; Animals; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Sumatriptan | 2012 |
Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Flushing; Headache; Humans; Hypohidrosis; Middle Aged; Migraine Disorders; Nitroglycerin; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents | 2012 |
Role of 5-HT₁B/₁D receptors in the reduction of formalin-induced nociception and secondary allodynia/hyperalgesia produced by antimigraine drugs in rats.
Topics: Acute Pain; Animals; Biphenyl Compounds; Chronic Pain; Dihydroergotamine; Disease Models, Animal; Drug Therapy, Combination; Female; Formaldehyde; Hyperalgesia; Methysergide; Nociceptive Pain; Piperazines; Piperidones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Antagonists; Spiro Compounds; Sumatriptan | 2013 |
Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein.
Topics: Adolescent; Adult; Aged; Coronary Vessels; Dihydroergotamine; Female; Humans; Male; Meningeal Arteries; Middle Aged; Organ Culture Techniques; Saphenous Vein; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2015 |
Does the presence of aura inform us regarding migraine severity and response to treatment?
Topics: Dihydroergotamine; Female; Humans; Male; Migraine with Aura; Migraine without Aura; Sumatriptan; Vasoconstrictor Agents | 2015 |